BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 7737294)

  • 1. Interactions between the tyrosine kinases p56lck, p59fyn and p50csk in CD4 signaling in T cells.
    Baldari CT; Di Somma MM; Milia E; Bergman M; Telford JL
    Eur J Immunol; 1995 Apr; 25(4):919-25. PubMed ID: 7737294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD4-dependent and -independent association of protein tyrosine kinases to the T cell receptor/CD3 complex of CD4+ mouse T lymphocytes.
    Criado G; Feito MJ; Rojo JM
    Eur J Immunol; 1996 Jun; 26(6):1228-34. PubMed ID: 8647197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of distinct populations of PI-3 kinase activity following T-cell activation.
    Thompson PA; Gutkind JS; Robbins KC; Ledbetter JA; Bolen JB
    Oncogene; 1992 Apr; 7(4):719-25. PubMed ID: 1373484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of p56lck and p59fyn protein expression in thymocyte subsets, peripheral T cells, NK cells, and lymphoid cell lines.
    Olszowy MW; Leuchtmann PL; Veillette A; Shaw AS
    J Immunol; 1995 Nov; 155(9):4236-40. PubMed ID: 7594580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physical association of the cytoplasmic domain of CD2 with the tyrosine kinases p56lck and p59fyn.
    Carmo AM; Mason DW; Beyers AD
    Eur J Immunol; 1993 Sep; 23(9):2196-201. PubMed ID: 8103744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of tyrosine kinase p56lck with CD4 inhibits the induction of growth through the alpha beta T-cell receptor.
    Haughn L; Gratton S; Caron L; Sékaly RP; Veillette A; Julius M
    Nature; 1992 Jul; 358(6384):328-31. PubMed ID: 1322497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD5 acts as a tyrosine kinase substrate within a receptor complex comprising T-cell receptor zeta chain/CD3 and protein-tyrosine kinases p56lck and p59fyn.
    Burgess KE; Yamamoto M; Prasad KV; Rudd CE
    Proc Natl Acad Sci U S A; 1992 Oct; 89(19):9311-5. PubMed ID: 1384049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of T-cell responsiveness by the lymphocyte-specific tyrosine protein kinase p56lck.
    Abraham N; Miceli MC; Parnes JR; Veillette A
    Nature; 1991 Mar; 350(6313):62-6. PubMed ID: 1706070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of CD4:lck with the T cell receptor/CD3 complex induces early signaling events in the absence of CD45 tyrosine phosphatase.
    Deans JP; Kanner SB; Torres RM; Ledbetter JA
    Eur J Immunol; 1992 Mar; 22(3):661-8. PubMed ID: 1532148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MHC class I ligation of human T cells activates the ZAP70 and p56lck tyrosine kinases, leads to an alternative phenotype of the TCR/CD3 zeta-chain, and induces apoptosis.
    Skov S; Bregenholt S; Claesson MH
    J Immunol; 1997 Apr; 158(7):3189-96. PubMed ID: 9120273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Both T cell receptor (TcR)-CD3 complex and CD2 increase the tyrosine kinase activity of p56lck. CD2 can mediate TcR-CD3-independent and CD45-dependent activation of p56lck.
    Danielian S; Alcover A; Polissard L; Stefanescu M; Acuto O; Fischer S; Fagard R
    Eur J Immunol; 1992 Nov; 22(11):2915-21. PubMed ID: 1358625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p56Lck and p59Fyn regulate CD28 binding to phosphatidylinositol 3-kinase, growth factor receptor-bound protein GRB-2, and T cell-specific protein-tyrosine kinase ITK: implications for T-cell costimulation.
    Raab M; Cai YC; Bunnell SC; Heyeck SD; Berg LJ; Rudd CE
    Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8891-5. PubMed ID: 7568038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 glycoprotein gp120 disrupts CD4-p56lck/CD3-T cell receptor interactions and inhibits CD3 signaling.
    Hubert P; Bismuth G; Körner M; Debré P
    Eur J Immunol; 1995 May; 25(5):1417-25. PubMed ID: 7774645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein tyrosine kinase p59fyn is associated with the T cell receptor-CD3 complex in functional human lymphocytes.
    Gassmann M; Guttinger M; Amrein KE; Burn P
    Eur J Immunol; 1992 Jan; 22(1):283-6. PubMed ID: 1530920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a signaling complex involving CD2, zeta chain and p59fyn in T lymphocytes.
    Gassmann M; Amrein KE; Flint NA; Schraven B; Burn P
    Eur J Immunol; 1994 Jan; 24(1):139-44. PubMed ID: 7912674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The p56lck SH2 domain mediates recruitment of CD8/p56lck to the activated T cell receptor/CD3/zeta complex.
    Thome M; Germain V; DiSanto JP; Acuto O
    Eur J Immunol; 1996 Sep; 26(9):2093-2100. PubMed ID: 8814252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 down-regulates CD4 costimulation of TCR/CD3-directed tyrosine phosphorylation through CD4/p56lck dissociation.
    Kanner SB; Haffar OK
    J Immunol; 1995 Mar; 154(6):2996-3005. PubMed ID: 7876562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. gp120 ligation of CD4 induces p56lck activation and TCR desensitization independent of TCR tyrosine phosphorylation.
    Goldman F; Jensen WA; Johnson GL; Heasley L; Cambier JC
    J Immunol; 1994 Oct; 153(7):2905-17. PubMed ID: 7522245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cells infiltrating non-Hodgkin's B cell lymphomas show altered tyrosine phosphorylation pattern even though T cell receptor/CD3-associated kinases are present.
    Wang Q; Stanley J; Kudoh S; Myles J; Kolenko V; Yi T; Tubbs R; Bukowski R; Finke J
    J Immunol; 1995 Aug; 155(3):1382-92. PubMed ID: 7636203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signal transduction through decay-accelerating factor. Interaction of glycosyl-phosphatidylinositol anchor and protein tyrosine kinases p56lck and p59fyn 1.
    Shenoy-Scaria AM; Kwong J; Fujita T; Olszowy MW; Shaw AS; Lublin DM
    J Immunol; 1992 Dec; 149(11):3535-41. PubMed ID: 1385527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.